Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
7.99
0.44%
After-hours: Aug 15, 2025, 05:59 PM EDT

Capricor Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.29M 14.69M 9.6M 34.89M
Short-Term Investments
140.23M 24.79M 31.82M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
221.7K 268.17K 268.17K 275.72K
Receivables
10.37M 10.37M 547.58K 391.75K
Inventory
n/a n/a n/a n/a
Other Current Assets
1.5M 995.78K 919.89K n/a
Total Current Assets
163.39M 50.86M 42.89M 36.44M
Property-Plant & Equipment
6.87M 7.61M 6.94M 4.62M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.1M 7.88M 7.21M 4.89M
Total Assets
170.48M 58.73M 50.09M 41.33M
Account Payables
8.18M 6.22M 4.83M n/a
Deferred Revenue
12M 24.27M 17.98M n/a
Short-Term Debt
834.8K n/a n/a n/a
Other Current Liabilities
-824.8K n/a n/a 3.72M
Total Current Liabilities
21.03M 31.27M 23.59M 4.13M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
3.38M 3.38M 3.38M 3.38M
Total Long-Term Liabilities
3.99M 4.86M 14.72M 5.83M
Total Liabilities
25.02M 36.13M 38.31M 9.96M
Total Debt
1.45M 2.24M 2.56M 2.87M
Common Stock
45.58K 31.15K 25.24K 24.18K
Retained Earnings
-199.83M -159.37M -137.08M -108.06M
Comprehensive Income
1.03M 235.81K 105.24K n/a
Shareholders Equity
145.46M 22.6M 11.79M 31.37M
Total Investments
140.23M 24.79M 31.82M n/a